Observational Registry of the Treatment of Glanzmann's Thrombasthenia

NCT01476423 · clinicaltrials.gov ↗

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Glanzmann's Disease

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S